Name: BCRX Balance Sheet - Biocryst Pharmaceuticals Assets & Debt | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Total Assets, Current Assets, Cash and Equivalents, Total Liabilities, Long-term Debt, Short-term Debt, Shareholders Equity, Working Capital, Book Value Per Share

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

BCRX - Biocryst Pharmaceuticals Inc.

USD | NASDAQ | Healthcare

BCRX Balance Sheet - Biocryst Pharmaceuticals Assets & Debt | Ledgeburg

(in millions of USD)	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012	FY2011	FY2010	FY2009	FY2008
Cash And Short Term Investments
Cash And Equivalents	89.7	104.7	110.6	304.8	504.4	272.1	114.2	26.7	50.3	22.1	28.9	54.5	21.2	20.9	-	13.6	41.1	22.3
Restricted Cash	0.2	1.6	1.8	1.5	3.3	2.2	1.6	1.5	3.3	1.5	1.6	0.2	0.2	0.3	-	0.6	-	-
Short Term Investments	185.0	216.1	-	-	-	-	-	-	-	-	-	-	-	-	-	40.3	-
Cash And Short Term Investments	274.7	320.9	110.6	304.8	504.4	272.1	114.2	26.7	50.3	22.1	28.9	54.5	21.2	20.9	-
Receivables
Accounts Receivable	106.8	79.1	57.0	50.6	29.4	8.6	22.1	4.3	6.1	8.8	6.2	3.8	2.1	4.6	-
Current Assets
Inventory	5.4	8.1	28.7	27.5	15.8	7.0	0.0	1.6	-	0.5	1.6	0.7	-	-	-	0.9
Non-Current Assets
Property, Plant & Equipment Gross	18.2	20.1	19.1	18.2	16.8	14.4	13.9	15.2	14.9	14.8	19.4	14.2	14.4	14.9
Current Liabilities
Accounts Payable	15.8	11.6	20.9	14.4	27.8	18.7	14.0	7.8	6.3	4.3	9.3	2.8	4.2	4.0	-
Non-Current Liabilities
Long Term Debt	0.0	314.9	303.2	231.6	136.1	119.7	0.0	30.0	23.0	23.0	-	-	-	-	-	-
Common Equity
Common Stock	2.1	2.1	2.1	1.9	1.8	1.8	1.5	1.1	1.0	0.7	0.7	0.7	0.6	0.5	70.0	0.5
Supplementary Data
Total Debt	0.0	314.9	303.2	231.6	136.1	119.7	0.0	30.0	23.0	23.0	-	-	-	-	-	-

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22	Q3 FY 22	Q2 FY 22	Q1 FY 22	Q4 FY 21	Q3 FY 21	Q2 FY 21	Q1 FY 21	Q4 FY 20	Q3 FY 20	Q2 FY 20	Q1 FY 20	Q4 FY 19	Q3 FY 19	Q2 FY 19	Q1 FY 19	Q4 FY 18	Q3 FY 18	Q2 FY 18	Q1 FY 18	Q4 FY 17	Q3 FY 17	Q2 FY 17	Q1 FY 17	Q4 FY 16	Q3 FY 16	Q2 FY 16
Cash And Short Term Investments
Cash And Equivalents	171.6	89.7	84.1	88.0	105.2	104.7	96.8	78.4	84.3	110.6	150.9	146.2	155.1	304.8	246.9

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Receivables
Accounts Receivable	109.3	106.8	91.3	91.2	93.4	79.1	72.5	68.8	60.6	57.0	53.6	57.7	48.6	50.6	42.6	41.5	36.4	29.4	26.2	27.6	18.4	8.6	5.4	4.0	5.6	22.1	3.6	3.6	5.0	4.3	3.4	2.3	5.7	6.1	9.0	3.3	9.6	8.8	6.0	2.2

Current Assets
Inventory	6.0	5.4	5.2	5.0	6.9	8.1	7.6	4.5	29.8	28.7	29.6	27.0	27.5	27.5	27.0	23.4	16.1	15.8	13.7	9.8	5.1	7.0	6.2	5.2	-	0.0	1.8	1.0	0.6	1.6	0.8	0.2	0.0	-	-	1.3	0.7	0.5	2.2	1.9
Prepaid Expenses	19.1	17.2	16.5	12.5	14.3	13.8	16.3	16.4	18.4	19.5	20.0	14.1	15.2	12.6	11.1	11.1	12.3	10.0
Other Current Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Assets Held For Sale	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Current Assets	373.6	404.3	355.7	398.5	410.0	422.0	427.1	363.5	447.1	496.0	502.5	511.1	490.9	516.5	509.0	494.9

Non-Current Assets
Property, Plant & Equipment Gross	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accumulated Depreciation	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Property,Plant & Equipment Net	9.4	8.8	8.4	8.5	7.6	7.8	7.4	7.7	7.8	7.9	9.0	8.4	8.4	8.6	8.5	8.7	8.8
Long Term Investments	20.6	61.2	39.7	10.1	20.5	20.3	19.4	64.3	-	0.0	0.0	3.4	3.4	18.1	34.3	0.0	0.0
Equity Method Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Goodwill	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Intangible Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Lease Right Of Use Assets	-	-	7.7	7.9	7.9	8.1	8.3	8.5	8.9	8.7	11.4	6.9	7.0	6.8	6.8	-
Deferred Tax Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Current Assets	19.7	5.7	4.4	3.6	4.9	5.2	15.6	12.5	13.0	13.1	11.5	6.9	7.0	6.8	6.8	7.0	7.2
Total Non-Current Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	465.1	514.2	446.4	457.2	480.0	490.4	491.3	472.4	467.9	517.0	522.9	529.9	509.7	550.0	558.6	510.5	527.7

Current Liabilities
Accounts Payable	11.0	15.8	5.6	8.6	10.0	11.6	13.5	7.8	11.9	20.9	10.6	13.9	6.3	14.4	8.6	12.0	13.9	27.8	19.7	10.1	13.5	18.7	11.6	9.4	10.1	14.0	10.1	8.3	6.9	7.8	7.9	4.1	3.6	6.3	4.6	1.8	5.4	4.3	2.8	5.1
Short Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue Current	5.4	0.0	-	-	-	-	-	-	-	-	0.5	1.8	1.2	1.2	1.6	1.5	1.5
Operating Lease Liabilities Current	1.9	0.3	0.3	0.4	1.1	0.9	1.0	1.0	1.1	1.1	2.3	2.5	2.5	2.4	2.2	2.1
Accrued Expenses	119.4	126.4	118.8	107.1	92.6	113.3	104.2	89.6	79.2	102.9	77.4	75.3	75.2	87.6	69.3	79.7	63.6
Other Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Current Liabilities	195.4	196.1	190.2	177.2	139.9	160.4	153.6	129.1	119.9	150.0	90.8	93.5	85.2	105.5	81.6

Non-Current Liabilities
Long Term Debt	395.2	0.0	194.4	242.8	315.4	314.9	314.3	313.8	308.5	303.2	298.0	293.2	232.5	231.6	223.9	144.5	140.2	136.1	132.1	126.8	123.0	119.7	45.0	50.0	50.0	-	50.0	50.0	50.0	-	30.0	19.6	21.3	-	23.0	23.0	23.0	-	-	-
Operating Lease Liabilities Non-Current	11.1	8.6	8.4	8.5	7.8	7.9	8.1	8.4	8.6	8.4	10.0	5.8	5.9	5.8	6.0	6.2
Deferred Revenue Non-Current	8.8	0.0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Tax Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Pension Obligations	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non-Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	1,018.9	633.3	834.3	878.8	932.0	966.4	959.8	948.0	944.1	972.5	933.9	918.6	838.0	844.6	801.3	723.8

Common Equity
Common Stock	2.5	2.1	2.1	2.1	2.1	2.1	2.1	2.1	2.1	2.1	1.9	1.9	1.9	1.9	1.9	1.9	1.9	1.8	1.8	1.8	1.8	1.8	1.8	1.8	1.5	1.5	1.1	1.1	1.1	1.1	1.1	1.0	1.0	1.0	1.0	0.8	0.8	0.7	0.7	0.7
Additional Paid In Capital	1,672.0	1,384.9	1,360.9	1,339.6	1,314.9	1,291.1	1,270.3	1,251.0	1,237.5	1,222.2	1,205.7	1,192.0	1,177.2	1,158.1	1,138.7	1,125.5
Retained Earnings	(2,228.0)	(1,506.2)	(1,752.0)	(1,764.9)	(1,770.0)	(1,770.0)	(1,743.2)	(1,729.2)	(1,716.5)	(1,681.2)	(1,619.4)	(1,583.3)	(1,508.0)	(1,454.6)	(1,383.1)	(1,340.6)	(1,281.7)
Accumulated Other Comprehensive Income	(0.4)	0.0	1.1	1.6	1.1	0.9	2.3	0.6	0.8	1.3	0.8	0.7	0.6	0.0	(0.1)	0.0
Treasury Stock	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Minority Interest	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Stockholders Equity	(553.8)	(119.2)	(387.9)	(421.6)	(451.9)	(475.9)	(468.6)	(475.6)	(476.2)	(455.5)	(411.0)	(388.7)	(328.3)	(294.6)	(242.7)	(213.2)
Total Equity	(553.8)	(119.2)	(387.9)	(421.6)	(451.9)	(475.9)	(468.6)	(475.6)	(476.2)	(455.5)	(411.0)	(388.7)	(328.3)	(294.6)	(242.7)	(213.2)	(164.2)	(107.0)